Angiotensin II Type-1 Receptor Antagonist as Well as Angiotensin Converying Enzyme Inhibitor Attenuates the Development of Heart Failure in Aortocaval Fistula Rats.
Toshio Nishikimi(Kyoto University), Tadanao Takeda, Shiro Yanagi, Hiroyuki Yamagishi(Tokyo Metropolitan Children's Medical Center), Kaname Akioka(Osaka City University), Tomoko Tani, Takashi Ohmura, Minoru Yoshiyama(Osaka City University), Iku Toda, Kazuhide Takeuchi, Masakazu Teragaki(Osaka City University)
Cited by 11
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478